BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 12933876)

  • 1. Both the Fas ligand and inducible nitric oxide synthase are needed for control of parasite replication within lesions in mice infected with Leishmania major whereas the contribution of tumor necrosis factor is minimal.
    Chakour R; Guler R; Bugnon M; Allenbach C; Garcia I; Mauël J; Louis J; Tacchini-Cottier F
    Infect Immun; 2003 Sep; 71(9):5287-95. PubMed ID: 12933876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TNF but not Fas ligand provides protective anti-L. major immunity in C57BL/6 mice.
    Wilhelm P; Wiede F; Meissner A; Donhauser N; Bogdan C; Körner H
    Microbes Infect; 2005 Dec; 7(15):1461-8. PubMed ID: 16269265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mice lacking the TNF receptor p55 fail to resolve lesions caused by infection with Leishmania major, but control parasite replication.
    Vieira LQ; Goldschmidt M; Nashleanas M; Pfeffer K; Mak T; Scott P
    J Immunol; 1996 Jul; 157(2):827-35. PubMed ID: 8752935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapidly fatal leishmaniasis in resistant C57BL/6 mice lacking TNF.
    Wilhelm P; Ritter U; Labbow S; Donhauser N; Röllinghoff M; Bogdan C; Körner H
    J Immunol; 2001 Mar; 166(6):4012-9. PubMed ID: 11238648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of Leishmania major infection in mice lacking TNF receptors.
    Nashleanas M; Kanaly S; Scott P
    J Immunol; 1998 Jun; 160(11):5506-13. PubMed ID: 9605154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TNF-alpha mediates the induction of nitric oxide synthase in macrophages but not in neutrophils in experimental cutaneous leishmaniasis.
    Fonseca SG; Romão PR; Figueiredo F; Morais RH; Lima HC; Ferreira SH; Cunha FQ
    Eur J Immunol; 2003 Aug; 33(8):2297-306. PubMed ID: 12884305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An essential role for transmembrane TNF in the resolution of the inflammatory lesion induced by Leishmania major infection.
    Allenbach C; Launois P; Mueller C; Tacchini-Cottier F
    Eur J Immunol; 2008 Mar; 38(3):720-31. PubMed ID: 18266271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The resolution of lesions induced by Leishmania major in mice requires a functional Fas (APO-1, CD95) pathway of cytotoxicity.
    Conceição-Silva F; Hahne M; Schröter M; Louis J; Tschopp J
    Eur J Immunol; 1998 Jan; 28(1):237-45. PubMed ID: 9485203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early infection with Leishmania major restrains pathogenic response to Leishmania amazonensis and parasite growth.
    González-Lombana CZ; Santiago HC; Macedo JP; Seixas VA; Russo RC; Tafuri WL; Afonso LC; Vieira LQ
    Acta Trop; 2008 Apr; 106(1):27-38. PubMed ID: 18313021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skin-derived macrophages from Leishmania major-susceptible mice exhibit interleukin-12- and interferon-gamma-independent nitric oxide production and parasite killing after treatment with immunostimulatory DNA.
    von Stebut E; Belkaid Y; Nguyen B; Wilson M; Sacks DL; Udey MC
    J Invest Dermatol; 2002 Sep; 119(3):621-8. PubMed ID: 12230504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential properties of CBA/J mononuclear phagocytes recovered from an inflammatory site and probed with two different species of Leishmania.
    Gomes IN; Calabrich AF; Tavares Rda S; Wietzerbin J; de Freitas LA; Veras PS
    Microbes Infect; 2003 Apr; 5(4):251-60. PubMed ID: 12706438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TNF-alpha controls intracellular mycobacterial growth by both inducible nitric oxide synthase-dependent and inducible nitric oxide synthase-independent pathways.
    Bekker LG; Freeman S; Murray PJ; Ryffel B; Kaplan G
    J Immunol; 2001 Jun; 166(11):6728-34. PubMed ID: 11359829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Migration inhibitory factor induces killing of Leishmania major by macrophages: dependence on reactive nitrogen intermediates and endogenous TNF-alpha.
    Jüttner S; Bernhagen J; Metz CN; Röllinghoff M; Bucala R; Gessner A
    J Immunol; 1998 Sep; 161(5):2383-90. PubMed ID: 9725234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effector cells of both nonhemopoietic and hemopoietic origin are required for interferon (IFN)-gamma- and tumor necrosis factor (TNF)-alpha-dependent host resistance to the intracellular pathogen, Toxoplasma gondii.
    Yap GS; Sher A
    J Exp Med; 1999 Apr; 189(7):1083-92. PubMed ID: 10190899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TNF contributes to the immunopathology of perforin/Fas ligand double deficiency.
    Cretney E; Street SE; Smyth MJ
    Immunol Cell Biol; 2002 Oct; 80(5):436-40. PubMed ID: 12225379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased susceptibility of Fas ligand-deficient gld mice to Trypanosoma cruzi infection due to a Th2-biased host immune response.
    Lopes MF; Nunes MP; Henriques-Pons A; Giese N; Morse HC; Davidson WF; Araújo-Jorge TC; DosReis GA
    Eur J Immunol; 1999 Jan; 29(1):81-9. PubMed ID: 9933089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new function of the Fas-FasL pathway in macrophage activation.
    Chakour R; Allenbach C; Desgranges F; Charmoy M; Mauel J; Garcia I; Launois P; Louis J; Tacchini-Cottier F
    J Leukoc Biol; 2009 Jul; 86(1):81-90. PubMed ID: 19380712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effective clearance of intracellular Leishmania major in vivo requires Pten in macrophages.
    Kuroda S; Nishio M; Sasaki T; Horie Y; Kawahara K; Sasaki M; Natsui M; Matozaki T; Tezuka H; Ohteki T; Förster I; Mak TW; Nakano T; Suzuki A
    Eur J Immunol; 2008 May; 38(5):1331-40. PubMed ID: 18398930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The hamster as a model of human visceral leishmaniasis: progressive disease and impaired generation of nitric oxide in the face of a prominent Th1-like cytokine response.
    Melby PC; Chandrasekar B; Zhao W; Coe JE
    J Immunol; 2001 Feb; 166(3):1912-20. PubMed ID: 11160239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activated macrophages direct apoptosis and suppress mitosis of mesangial cells.
    Duffield JS; Erwig LP; Wei X; Liew FY; Rees AJ; Savill JS
    J Immunol; 2000 Feb; 164(4):2110-9. PubMed ID: 10657665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.